Valuation : Becton, Dickinson and Company

Market Cap 48.44B 41.8B 39.55B 35.84B 67.19B 4,628B 67.65B 468B 180B 2,353B 182B 178B 7,444B P/E 2026 *
34.3x
P/E 2027 * 19.1x
Enterprise Value 64.33B 55.5B 52.52B 47.59B 89.22B 6,146B 89.83B 622B 240B 3,124B 241B 236B 9,884B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.17x
Free-Float
73.18%
Yield 2026 *
2.21%
Yield 2027 * 2.24%
1 week-3.77%
Current month-5.31%
1 month-2.52%
3 months+20.24%
6 months+8.34%
Current year+16.43%
1 week 151.26
Extreme 151.26
158.5
1 month 151.26
Extreme 151.26
165.6
3 years 111.9
Extreme 111.90117625
201.94
5 years 111.9
Extreme 111.90117625
210.13
10 years 111.9
Extreme 111.90117625
210.13
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-5.96%+18.32%-22.28% 48.44B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.36%-5.08%+3.56%+5.17% 61.98B
Weighted average by Cap. -0.69%-4.90%-3.98%+8.06%

Financials

2026 *2027 *
Net sales 19.26B 16.62B 15.73B 14.25B 26.71B 1,840B 26.9B 186B 71.75B 935B 72.3B 70.73B 2,959B 19.69B 16.99B 16.08B 14.57B 27.31B 1,881B 27.49B 190B 73.35B 956B 73.91B 72.31B 3,025B
Net income 1.44B 1.24B 1.17B 1.06B 1.99B 137B 2.01B 13.88B 5.35B 69.77B 5.39B 5.28B 221B 2.34B 2.02B 1.91B 1.73B 3.24B 224B 3.27B 22.61B 8.72B 114B 8.78B 8.59B 359B
Net Debt 15.88B 13.7B 12.97B 11.75B 22.03B 1,518B 22.18B 153B 59.18B 771B 59.63B 58.34B 2,441B 13.95B 12.04B 11.39B 10.32B 19.35B 1,333B 19.48B 135B 51.97B 678B 52.37B 51.24B 2,144B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Date Price Change
26-09-11 €153.24 +0.91%
26-09-10 €151.86 -1.72%
26-09-09 €154.52 +0.35%
26-09-08 €153.98 -2.25%
26-09-07 €157.52 -1.08%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
177.85USD
Average target price
195.67USD
Spread / Average Target
+10.02%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!